Pharmaceutical Technology Department, National Research Centre, Dokki, Cairo 12622, Egypt.
Curr Drug Targets. 2018;19(15):1839-1854. doi: 10.2174/1389450119666180207092831.
Drug toxicity and inefficacy are commonly experienced problems with drug therapy failure. To face these problems, extensive research work took place aiming to design new dosage forms for drug delivery especially nanoparticulate systems. These systems are designed to increase the quantity of the therapeutic molecule delivered to the desired site concurrently with reduced side effects. In order to achieve this objective, nanocarriers must principally display suitable drug vehiculization abilities and a controlled biological destiny of drug molecules. Only the intelligent design of the nanomedicine will accomplish these fundamentals.
The present review article is dedicated to the discussion of the important fundamentals to be considered in the fabrication of nanomedicines. These include the therapeutic agent, the imaging agent, the nanocarrier and the functionalization moieties. Special consideration is devoted to the explanation and compilation of highly potential fabrication approaches assisting how to control the in vivo destiny of the nanomedicine. Finally, some nanotechnology-based drug delivery systems, for the development of nanomedicine, are also discussed.
The nanotechnology-based drug delivery systems show remarkable outcomes based on passive and active targeting as well as improvement of the drug pharmacodynamic and pharmacokinetic profiles. Multifunctional nanocarrier concept affords a revolutionary drug delivery approach for maximizing the efficacy, safety and monitoring the biological fate of the therapeutic molecule.
Nanomedicines may enhance the efficacy of therapeutic molecules and reduce their toxic effects. Meanwhile, further research works are required to rightly optimize (and define) the effectiveness, nanotoxicity, in vivo destiny and feasibility of these nanomedicines which, from a preclinical standpoint, are actually promising.
药物毒性和无效是药物治疗失败中常见的问题。为了应对这些问题,进行了广泛的研究工作,旨在设计新的药物传递剂型,特别是纳米颗粒系统。这些系统旨在增加递送到所需部位的治疗分子的数量,同时减少副作用。为了实现这一目标,纳米载体必须主要显示出合适的药物载体化能力和药物分子的受控生物学命运。只有智能设计的纳米医学才能实现这些基础。
本综述文章专门讨论了制造纳米医学时需要考虑的重要基础。这些包括治疗剂、成像剂、纳米载体和功能化部分。特别考虑了解释和编译高度有潜力的制造方法,以帮助控制纳米医学的体内命运。最后,还讨论了一些基于纳米技术的药物传递系统,用于开发纳米医学。
基于纳米技术的药物传递系统通过被动和主动靶向以及改善药物药效学和药代动力学特征显示出显著的效果。多功能纳米载体概念为最大限度地提高治疗分子的疗效、安全性和监测其生物命运提供了一种革命性的药物传递方法。
纳米医学可以提高治疗分子的疗效,降低其毒性作用。同时,需要进一步的研究工作来正确优化(和定义)这些纳米医学的有效性、纳米毒性、体内命运和可行性,从临床前的角度来看,这些纳米医学实际上是有前途的。